SCHEMBL20766941

SCHEMBL20766941

Clc1ccccc1-c1ncc2ccccn12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.83
KDM4E B2RXH2 10/20 0.83
MEN1 O00255 5/20 0.72
KMT2A Q03164 5/20 0.72
MAPK1 P28482 2/20 0.61
MAPT P10636 6/20 0.59
CHEK1 O14757 1/20 0.59
LIMK1 P53667 1/20 0.59
MAPK14 Q16539 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
RAB9A P51151 7/20 0.53
NPC1 O15118 4/20 0.53
HSD17B10 Q99714 3/20 0.51
POLB P06746 1/20 0.51
HPGD P15428 7/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
GLA P06280 2/20 0.47
GAA P10253 2/20 0.47
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3900072 0.77 KDM4E (0.56) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL22718492 0.77 KDM4E (0.61) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL20767014 0.76 MEN1 (0.56) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL2284269 0.74 ALDH1A1 (0.57) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL11534549 0.74 KDM4E (1.00) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL16796325 0.73 KDM4E (0.65) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL23508915 0.72 ALDH1A1 (0.49) ALDH1A1KDM4EMEN1KMT2ARAB9A
SCHEMBL20610586 0.71 ALDH1A1 (0.55) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL13325866 0.70 ALDH1A1 (0.77) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL948580 0.70 KDM4E (0.77) ALDH1A1KDM4EMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3672970-A1 THERAPEUTIC HETEROCYCLIC COMPOUNDS Gilead Sciences, Inc. (US) 2020-07-01 EP disclosed
WO-2019040102-A1 THERAPEUTIC HETEROCYCLIC COMPOUNDS GILEAD SCIENCES, INC. (US) 2019-02-28 WO disclosed